SALVALAIO, MARIKA
 Distribuzione geografica
Continente #
NA - Nord America 1.583
AS - Asia 747
EU - Europa 511
SA - Sud America 166
AF - Africa 143
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 5
Totale 3.180
Nazione #
US - Stati Uniti d'America 1.489
SG - Singapore 267
CN - Cina 166
IT - Italia 146
BR - Brasile 121
HK - Hong Kong 75
VN - Vietnam 51
FI - Finlandia 48
SE - Svezia 42
DE - Germania 41
PL - Polonia 27
GB - Regno Unito 26
FR - Francia 23
NL - Olanda 21
IN - India 19
RU - Federazione Russa 16
KR - Corea 15
MX - Messico 15
UA - Ucraina 15
AR - Argentina 13
ID - Indonesia 13
TR - Turchia 13
JP - Giappone 12
CR - Costa Rica 11
PA - Panama 11
BJ - Benin 10
AT - Austria 8
CA - Canada 8
UZ - Uzbekistan 8
ZA - Sudafrica 8
AL - Albania 7
BD - Bangladesh 7
EC - Ecuador 7
ML - Mali 7
NZ - Nuova Zelanda 7
SN - Senegal 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CH - Svizzera 6
CI - Costa d'Avorio 6
ES - Italia 6
IQ - Iraq 6
PK - Pakistan 6
SO - Somalia 6
TW - Taiwan 6
UG - Uganda 6
AO - Angola 5
BE - Belgio 5
BW - Botswana 5
BY - Bielorussia 5
CL - Cile 5
CU - Cuba 5
GE - Georgia 5
GH - Ghana 5
GM - Gambi 5
IE - Irlanda 5
JM - Giamaica 5
JO - Giordania 5
LC - Santa Lucia 5
MK - Macedonia 5
NC - Nuova Caledonia 5
PT - Portogallo 5
RE - Reunion 5
SI - Slovenia 5
TH - Thailandia 5
TL - Timor Orientale 5
AM - Armenia 4
CD - Congo 4
CO - Colombia 4
CZ - Repubblica Ceca 4
EE - Estonia 4
GA - Gabon 4
GT - Guatemala 4
IR - Iran 4
KH - Cambogia 4
LA - Repubblica Popolare Democratica del Laos 4
LU - Lussemburgo 4
MA - Marocco 4
MY - Malesia 4
PF - Polinesia Francese 4
PH - Filippine 4
PS - Palestinian Territory 4
PY - Paraguay 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TJ - Tagikistan 4
TT - Trinidad e Tobago 4
VC - Saint Vincent e Grenadine 4
ZM - Zambia 4
BB - Barbados 3
BG - Bulgaria 3
BO - Bolivia 3
CM - Camerun 3
CV - Capo Verde 3
CW - ???statistics.table.value.countryCode.CW??? 3
CY - Cipro 3
DZ - Algeria 3
ET - Etiopia 3
GP - Guadalupe 3
GR - Grecia 3
Totale 3.065
Città #
Ashburn 203
Singapore 147
Fairfield 144
Chandler 127
Ann Arbor 120
Houston 116
Woodbridge 90
Cambridge 68
Hong Kong 68
Beijing 52
Wilmington 51
Seattle 49
Padova 37
Helsinki 33
Boardman 32
Jacksonville 31
Santa Clara 28
Los Angeles 23
New York 22
Bytom 21
Ho Chi Minh City 19
Princeton 17
Medford 15
Des Moines 14
Munich 14
Council Bluffs 13
Hanoi 13
Nanjing 12
Chicago 11
San Diego 11
Tokyo 11
Cotonou 10
San José 10
Buffalo 9
Nuremberg 9
Panama City 9
Milan 8
São Paulo 8
Dakar 7
Istanbul 7
Abidjan 6
Bamako 6
Cagliari 6
Kampala 6
Rome 6
Tashkent 6
Turku 6
Vicenza 6
Amman 5
Amsterdam 5
Auckland 5
Castries 5
Dili 5
Falls Church 5
Guangzhou 5
Hargeisa 5
Hefei 5
Jinan 5
Kingston 5
Mexico City 5
Nanchang 5
Noumea 5
Phoenix 5
Redondo Beach 5
Roxbury 5
Tbilisi 5
Tirana 5
Accra 4
Atlanta 4
Belo Horizonte 4
Brooklyn 4
Catania 4
Dushanbe 4
Falkenstein 4
Gaborone 4
Haiphong 4
Havana 4
Kingstown 4
Kinshasa 4
Libreville 4
London 4
Lusaka 4
Minsk 4
Montebelluna 4
Oakland 4
Phnom Penh 4
Poplar 4
Venice 4
Vienna 4
Vientiane 4
Yerevan 4
Abu Dhabi 3
Athens 3
Auburn Hills 3
Baghdad 3
Bangkok 3
Banjul 3
Bishkek 3
Boston 3
Brasília 3
Totale 1.955
Nome #
Perturbations in cell signaling elicit early cardiac defects in mucopolysaccharidosis type II 270
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 238
Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates 235
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment 224
Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model 210
RNA-seq Transcriptome Profiling Of Primary Hunter Cells Following Treatment With Recombinant IDS As A First Step For Identification Of ERT Efficacy Markers 196
FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII). 195
Valutazione del profilo di espressione genica cerebrale nel modello murino per la mucopolisaccaridosi di tipo II (sindrome di Hunter) effettuata mediante tecnologia RNA-Seq 175
Targeting brain disease in MPSII: Preclinical evaluation of IDS-loaded PLGA nanoparticles 169
Browning Effects of a Chronic Pterostilbene Supplementation in Mice Fed a High-Fat Diet 151
In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target 149
Loss of lysosomal iduronate sulfatase function perturbs FGF signaling and the expression of downstream key osteogenic factors. 147
The zebrafish model as a novel tool to uncover the complex bone pathogenesis of type I Gaucher disease 135
Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II. 132
BBB Crossing in Lysosomal Storage Disorders: A Nanoparticle-Based Approach 130
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 122
Brain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model 115
Corrigendum: FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII) [Human Molecular Genetics, 27, 13, (2018) (2262-2275)] DOI: 10.1093/hmg/ddy131 110
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy 105
Totale 3.208
Categoria #
all - tutte 10.557
article - articoli 8.607
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.164


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021182 0 0 0 0 0 10 22 24 34 53 26 13
2021/2022247 11 25 30 14 28 16 13 25 15 7 16 47
2022/2023258 32 29 6 30 46 34 0 19 43 9 8 2
2023/2024205 12 21 24 20 14 31 15 17 6 11 21 13
2024/2025593 9 39 30 26 48 19 40 60 41 32 97 152
2025/20261.155 148 183 247 291 241 45 0 0 0 0 0 0
Totale 3.208